Prodia (PRDA) Prepare Capex of IDR 300 Billion, Continues Expansion

LISTED COMPANY - JAKARTA. PT Prodia Widyahusada Tbk (PRDA) has announced a significant investment in the procurement of next-generation laboratory services with cobas® connection Modules, a cutting-edge information technology (IT) feature for clinical chemistry and immunoassay examinations. 

PRDA's CEO, Dewi Muliaty, acknowledges that the expenditure is substantial. However, she assures that the spending aligns with their calculated projections.